Suppr超能文献

慢性鼻炎的H1受体拮抗剂治疗

H1 receptor antagonist treatment of chronic rhinitis.

作者信息

Simons F E, Simons K J

机构信息

Department of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba, Canada.

出版信息

J Allergy Clin Immunol. 1988 May;81(5 Pt 2):975-80. doi: 10.1016/0091-6749(88)90164-9.

Abstract

In patients with chronic rhinitis, H1 receptor antagonists play an important role in relieving the symptoms of sneezing, itching, and rhinorrhea. New information about the pharmacokinetics and pharmacodynamics of first-generation H1 receptor antagonists such as chlorpheniramine has become available in the past few years. Comprehensive pharmacokinetic and pharmacodynamic studies of new relatively nonsedating H1 receptor antagonists such as terfenadine, astemizole, loratadine, and cetirizine are appearing. An understanding of the differences in pharmacokinetics and pharmacodynamics among H1 receptor antagonists is required for optimal use of these drugs.

摘要

在慢性鼻炎患者中,H1受体拮抗剂在缓解打喷嚏、瘙痒和流涕症状方面发挥着重要作用。在过去几年里,已获得有关第一代H1受体拮抗剂如氯苯那敏的药代动力学和药效学的新信息。关于新的相对无镇静作用的H1受体拮抗剂如特非那定、阿司咪唑、氯雷他定和西替利嗪的全面药代动力学和药效学研究正在出现。为了最佳地使用这些药物,需要了解H1受体拮抗剂之间药代动力学和药效学的差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验